Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage

Journal of Applied Toxicology

Volumn 33, Issue 9, 2013, Pages 970-979

  Arauz, Jonathan ^a   Moreno, Marina Galicia ^a   Cortés Reynosa, Pedro ^a   Salazar, Eduardo Pérez ^a   Muriel, Pablo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Antioxidants; Coffee; CTGF; Liver injury; TGF ; Thioacetamide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ANTIOXIDANT; CAFESTOL; CAFFEINE; COLLAGEN; COLLAGENASE 3; CONNECTIVE TISSUE GROWTH FACTOR; GAMMA GLUTAMYLTRANSFERASE; GELATINASE A; GELATINASE B; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; INTERLEUKIN 10; KAHWEOL; LIVER PROTECTIVE AGENT; OIL; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; BODY WEIGHT; COFFEE; CONTROLLED STUDY; DRINKING; ENZYME ACTIVITY; FIBROGENESIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HISTOPATHOLOGY; INTOXICATION; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PROTECTION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPEATED DRUG DOSE; STELLATE CELL; ZYMOGRAPHY;

ANTIOXIDANTS; COFFEE; CTGF; LIVER INJURY; TGF-Β; THIOACETAMIDE;

ACTINS; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTIOXIDANTS; COFFEE; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; FIBROSIS; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; LIVER; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; THIOACETAMIDE; TRANSFORMING GROWTH FACTOR BETA;

MURINAE; RATTUS NORVEGICUS;

EID: 84880699422     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2788     Document Type: Article

References (49)

1. Bataller R, Brenner DA. 2005. Liver fibrosis. J. Clin. Invest. 115: 209-218.
2. Benoit S, Christophe C, Angelika T, Anne C. 2001. Health effects and safety considerations. In Coffee Recent Developments, Agricultural Series, Clarke RJ, Vitzthum OG (eds). 165-183.
3. Benyon RC, Arthur MJ. 2001. Extracellular matrix degradation and the role of hepatic stellate cells. Semin. Liver Dis. 21: 373-384.
4. Bergmeyer HU, Grabl M, Walter HE. 1983. Enzymes. In Methods of Enzymatic Analysis, Bergmeyer J, Grabl M (eds). Verlag-Chemie: Weinheim; 269-270.
5. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72: 248-254.
6. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, Schadevan Westrum S, Crabbe T, Clements J, d'Ortho MP, Murphy G. 1998. The TIMP2 membrane type 1 metalloproteinase "Receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273: 871-880.
7. Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E. 2005. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig. Liver Dis. 37: 349-356.
8. Consolo M, Amoroso A, Spandidos DA, Mazzarino MC. 2009. Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). Int. J. Mol. Med. 24: 143-152.
9. Corrao G, Zambon A, Bagnardi V, D'amicis A, Klatsky A. 2001. Collaborative SIDECIR Group. Coffee, caffeine, and the risk of liver cirrhosis. Ann. Epidemiol. 11: 458-465.
10. Daglia M, Papetti A, Gregotti C, Berte F, Gazzani G. 2000. In vitro antioxidant and ex vivo protective activities of green and roasted coffee. J. Agric. Food Chem. 48: 1449-1454.
11. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
12. De Minicis S, Brenner D. 2008. Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. J. Gastroenterol. Hepatol. 23: S98-S103.
13. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. 1999. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down regulation by cAMP. FASEB J. 13: 1774-1786.
14. Etique N, Grillier Vuissoz I, Flament S. 2006. Ethanol stimulates the secretion of matrix metalloproteinases 2 and 9 in MCF-7 human breast cancer cells. Oncol. Rep. 15: 603-608.
15. Friedman SL. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275: 2247-2250.
16. Friedman SL. 2003. Liver fibrosis - from bench to bedside. J. Hepatol. 38(S1): S38-S53.
17. García-Tovar CG, Perez A, Luna J, Mena R, Osorio B, Aleman V, Mondragon R, Mornet D, Rendón A, Hernandez JM. 2001. Biochemical and histochemical analysis of 71 kDa dystrophin isoform (Dp71f) in rat brain. Acta Histochem. 103: 209-224.
18. Glossman M, Neville DM. 1972. Glutamyl transferase in kidney brush border membranes. FEBS Lett. 19: 340-344.
19. Geerts PD. 2001. History, heterogeneity, developmental, biology, and functions of quiescent hepatic stellate cells. Semin. Liver Dis. 21: 311-335.
20. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. 2002. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7: 793-807.
21. Gressner AM, Weiskirchen R. 2006. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J. Cell. Mol. Med. 10: 76-99.
22. Gressner OA, Lahme B, Siluschek M, Rehbein K, Weiskirchen R, Gressner AM. 2008a. Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. J. Cell. Mol. Med. 12: 2717-2730.
23. Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM. 2008b. Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARγ and SMAD2/3-dependent pathways. J. Hepatol. 49: 758-767.
24. Heussen C, Dowdle EB. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102: 196-202.
25. Higdon JV, Frei B. 2006. Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr. 46: 101-123.
26. Hung KS, Lee TH, Chou WY, Wu CL, Cho CL, Lu CN, Jawan B, Wang CH. 2005. Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice. Biochem. Biophys. Res. Commun. 14(336): 324-331.
27. Klatsky AL, Armstrong MA, Friedman GD. 1993. Coffee, tea, and mortality. Ann. Epidemiol. 3: 375-381.
28. La Vecchia CL. 2005. Coffee, liver enzymes, cirrhosis and liver cancer. J. Hepatol. 42: 444-446.
29. Lawrence RA, Burk RF. 1976. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 23: 952-958.
30. McCusker RR, Goldberger BA, Cone EJ. 2003. Caffeine content of specialty coffees. J. Anal. Toxicol. 27: 520-522.
31. Muriel P, Arauz J. 2010. Coffee and liver diseases. Fitoterapia 81: 297-305.
32. Natarajan SK, Thomas S, Ramamoorthy P, Basivireddy J, Pulimood AB, Ramachandran A, Balasubramanian KA. 2006. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J. Gastroenterol. Hepatol. 21: 947-957.
33. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by the thiobarbituric acid reaction. Anal. Biochem. 95: 351-358.
34. Park SY, Shin HW, Lee KB, Lee MJ, Jang JJ. 2010. Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury. J. Korean Med. Sci. 25: 570-576.
35. Perlemuter G, Letteron P, Carnot F, Zavala F, Pessayre D, Nalpas B, Brechot C. 2003. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J. Hepatol. 39: 1020-1027.
36. Prockop DJ, Underfriend S. 1960. A specific method for the analysis of hydroxyproline in tissues and urine. Anal. Biochem. 1: 228-239.
37. Reitman S, Frankel S. 1957. A colorimetric method for determination of serum oxaloacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 28: 56-63.
38. Rosen H, Keeffe E. 2000. Evaluation of abnormal liver enzymes, use of liver tests, and the serology of viral hepatitis. In Liver Disease: Diagnosis and Management, Bacon B, DiBisceglie AM (eds). Plenum Press: New York; 24-35.
39. Safadi R, Friedman SL. 2002. Hepatic fibrosis - role of hepatic stellate cell activation. MedGenMed 15: 4-27.
40. Sanchez GI, Jimenez EF, Saura CF. 2005. In vitro antioxidant activity of coffees brewed using different procedures (Italian, espresso and filter). Food Chem. 90: 133-139.
41. Schmitt Graff A, Kruger S, Bochard F, Gabbiani G, Denk H. 1991. Modulation of alpha smooth muscle actin and desmin expression in peris-inusoidal cells of normal and diseased human livers. Am. J. Pathol. 138: 1233-1242.
42. Seifter S, Dayton S, Novic B, Muntwyler E. 1950. The estimation of glycogen with the anthrone reagent. Arch. Biochem. 25: 191-200.
43. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700
44. Spiller MA. 1998. The chemical components of coffee. In Caffeine, Spiller GA (ed.). Boca Raton: CRC Press; 97-161.
45. Tilg H, Diehl AM. 2000. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343: 1467-1476.
46. Tverdal A, Skurtveit S. 2003. Coffee intake and mortality from liver cirrhosis. Ann. Epidemiol. 13: 419-423.
47. Wells RG. 2000. Fibrogenesis V. TGF-beta signaling pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G845-G850
48. Weng HL, Ciuclan L, Liu Y, Hamzavi J, Godoy P, Gaitantzi H, Kanzler S, Heuchel R, Ueberham U, Gebhardt R, Breitkopf K, Dooley S. 2007. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 46: 1257-1270.
49. Zeisberg M, Yang C, Martino M, Dunca M, Rieder F, Tanjore H, Kalluri R. 2007. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282: 23337-23347.